Filters

Fengyuan Qi, Shangrong Fan, Chao Fang, Lan Ge, Jinli Lyu, Zhuoqi Huang, Shaowei Zhao, Yuanqiang Zou, Liting Huang, Xinyang Liu, Yiheng Liang, Yongke Zhang, Yiyi Zhong, Haifeng Zhang, Liang Xiao, Xiaowei Zhang

Frontiers in immunology 2023;14():1125239

Plain Language Summary

Free Full Text

Abstract

Oral administration of Lactobacillus crispatus M247 to papillomavirus-infected women: results of a preliminary, uncontrolled, open trial.

Francesco DI Pierro, Anna A Criscuolo, Anna Dei Giudici, Roberto Senatori, Francesco Sesti, Marco Ciotti, Emilio Piccione

Minerva obstetrics and gynecology 2021;73(5):621-631

Plain Language Summary

Free Full Text

Abstract

Reviewing the Composition of Vaginal Microbiota: Inclusion of Nutrition and Probiotic Factors in the Maintenance of Eubiosis.

Antonio Barrientos-Durán, Ana Fuentes-López, Adolfo de Salazar, Julio Plaza-Díaz, Federico García

Nutrients 2020;12(2):419

Free Full Text

Abstract

CECT 30648 shows probiotic characteristics and colonizes the vagina of healthy women after oral administration.

Marta Perez, Maria Rodriguez-Palmero, Ana Aldea-Perona, Pol Huedo, Antonio Del Casale, Jordi Espadaler-Mazo, Eva Armengol, Ilenia Campedelli, Marta Pérez Otero

Microbiology spectrum 2025;13(9):e0021125

Free Full Text

Abstract

Effectiveness of vaginal probiotics chen-01 in women with high-risk HPV infection: a prospective controlled pilot study.

Fei Wu, Tingtao Chen, Jie Chen, Yujuan Liu, Xiumiao Zhao, Juanzhen Luo, Chunling Wu

Aging 2024;16(14):11446-11459

Free Full Text

Abstract

Effect of the vaginal live biotherapeutic LACTIN-V (Lactobacillus crispatus CTV-05) on vaginal microbiota and genital tract inflammation among women at high risk of HIV acquisition in South Africa: a phase 2, randomised, placebo-controlled trial.

Agnes Bergerat, Anke Hemmerling, Douglas S Kwon, Craig R Cohen, Vaneshree Govender, Thumbi Ndung'u, Caroline M Mitchell, Sinaye Ngcapu, Suuba Demby, Musie Ghebremichael, Joseph Elsherbini, Jiawu Xu, Nondumiso Xulu, Johnathan Shih, Krista Dong, Vanessa Pillay, Nasreen Ismail, Gardenia Casillas, Jayajothi Moodley, Tess Brunner, Lenine Liebenberg, Ian Mbano, Laurel Lagenaur, Thomas P Parks

The Lancet. Microbe 2025;6(6):101037

Free Full Text

Abstract

Vaginal fungi are associated with treatment-induced shifts in the vaginal microbiota and with a distinct genital immune profile.

Anke Hemmerling, Bryan Coburn, Maria Kulikova, Craig R Cohen, Steve Miller, Sanja Huibner, Rupert Kaul, Eric Armstrong, Rachel Liu, Emily Crawford, Gloria R Castañeda

Microbiology spectrum 2024;12(8):e0350123

Free Full Text

Abstract

Preterm-birth-prevention with Lactobacillus crispatus oral probiotics: Protocol for a double blinded randomised placebo-controlled trial (the PrePOP study).

Conor Feehily, Fionnuala M McAuliffe, David A MacIntyre, Paul D Cotter, Gillian A Corbett, Siobhan Corcoran, Benedetta Soldati, Anthony Rafferty

Contemporary clinical trials 2025;149():107776

Free Full Text

Abstract

Potential vaginal probiotics: safety, tolerability and preliminary effectiveness.

M Rostok, P Hütt, T Rööp, I Smidt, J Štšepetova, A Salumets, R Mändar

Beneficial microbes 2019;10(4):385-393

Full Text

Abstract

Results: 1 – 15 / 15

Filters

Expert Opinion

Clinical Imbalances

Modifiable Lifestyle Factors

Text Availability

Publication Types

Publication Year

Results for ""Lactobacillus crispatus""[mesh_terms]

The vaginal microbiome and the risk of preterm birth: a systematic review and network meta-analysis.

Human Milk Oligosaccharides Modulate Nitrogen Utilization in Lactobacillus crispatus in a Glucose-Dependent Manner.

Insights into host dependency from a chemically defined medium for the human vaginal bacterium Lactobacillus crispatus.

Impact of a multi-strain L. crispatus-based vaginal synbiotic on the vaginal microbiome: a randomized placebo-controlled trial.

Study of the effect of Lactobacillus FSCDJY67L3 on eradication: a double-blind randomized controlled clinical trial.

Safety, tolerability, and acceptability of CTV-05 (LACTIN-V) in pregnant women at high-risk of preterm birth.

Orally administrated TM13 and LG55 can restore the vaginal health of patients recovering from bacterial vaginosis.

Oral administration of Lactobacillus crispatus M247 to papillomavirus-infected women: results of a preliminary, uncontrolled, open trial.

Reviewing the Composition of Vaginal Microbiota: Inclusion of Nutrition and Probiotic Factors in the Maintenance of Eubiosis.

CECT 30648 shows probiotic characteristics and colonizes the vagina of healthy women after oral administration.

Effectiveness of vaginal probiotics chen-01 in women with high-risk HPV infection: a prospective controlled pilot study.

Effect of the vaginal live biotherapeutic LACTIN-V (Lactobacillus crispatus CTV-05) on vaginal microbiota and genital tract inflammation among women at high risk of HIV acquisition in South Africa: a phase 2, randomised, placebo-controlled trial.

Vaginal fungi are associated with treatment-induced shifts in the vaginal microbiota and with a distinct genital immune profile.

Preterm-birth-prevention with Lactobacillus crispatus oral probiotics: Protocol for a double blinded randomised placebo-controlled trial (the PrePOP study).

Potential vaginal probiotics: safety, tolerability and preliminary effectiveness.

Results for
""Lactobacillus crispatus""[mesh_terms]